←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS47%
R&D + SG&A16%
Op Margin37%
FINANCIAL HEALTH
REVENUE
$35.3B
Growth
21%
Gross M.
53%
P/E
61.4
EV/EBITDA
0
Net M.
30%
FCF M.
24%
D/E
0.19
Op M.
37%
PLUG INTO YOUR DCF
Historical growth
18.5%
Analyst 5y growth
—
Forward P/E
29.4
PEG ratio
2.20
Trailing EPS
$28.60
Forward EPS
$59.50
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
HIGTrading above a mechanical base-case DCF estimate of $1209.31 (default assumptions) — priced for continued strong execution.
LOWDebt/equity of 0.19 — conservative balance sheet.
LOWRevenue growing 21% YoY — steady, unspectacular growth.
🐂 BULL
ASML shows revenue grew +21.3% YoY, 37% operating margin, 54% ROE, a healthy 24% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 61.4, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.